The interplay between monosodium glutamate (MSG) consumption and metabolic disorders

Area of Science:

• Food Science and Nutrition
• Metabolic Health
• Toxicology

Background:

• Monosodium glutamate (MSG) is a globally prevalent food additive, with consumption exceeding three million metric tons annually.
• Asia, particularly China, dominates both the consumption and production of MSG.
• MSG use has been associated with increased risks of metabolic disorders, including obesity, hypertension, and diabetes mellitus.

Purpose of the Study:

• To review the scientific literature on the metabolic effects of Monosodium glutamate (MSG) consumption.
• To elucidate the mechanisms by which MSG contributes to metabolic disorders.
• To inform public health and regulatory bodies regarding safe MSG consumption levels.

Main Methods:

• Literature review of studies investigating MSG's impact on metabolic health.
• Analysis of research detailing the physiological and biochemical pathways affected by MSG.
• Examination of data on global MSG consumption patterns and trends.

Main Results:

• MSG consumption is implicated in the development of obesity through mechanisms like hypothalamic lesions, hyperlipidemia, and leptin resistance.
• MSG intake is linked to diabetes mellitus induction via decreased pancreatic beta cell mass, increased oxidative stress, and insulin resistance.
• The dietary salt component of MSG is a risk factor for hypertension, and MSG's use in tobacco products increases cancer risk.

Conclusions:

• Despite its widespread use and popularity, MSG consumption poses significant risks for metabolic disorders.
• Further research is needed to establish safe daily consumption limits for MSG based on observed metabolic toxicities.
• Public awareness and regulatory review are crucial for mitigating the health risks associated with high MSG intake.